Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
2025 RACP New Fellow Survey Results
Wednesday November 12, 2025
Find results on the NFS valuable data collection from new Fellows on the experience of the transition from Advanced Trai...
The NZSG Annual Report is Published
Tuesday November 11, 2025
NZSG has published Updated Guidelines
Tuesday November 11, 2025